Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2024 · 58 positions · Total reported value $1.20B · Top-10 concentration 62.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2024 13F filing, Sofinnova Investments, Inc. disclosed 58 equity positions with a combined reported value of $1.20B. The filing implies a focused portfolio: its ten largest positions account for 62.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were NTRA ($196.81M), VERA ($123.49M), NVO ($86.48M). By sector, the heaviest allocations are Health Care 92.0%, Industrials 0.3%. Versus the prior quarter, allocation shifted toward Health Care (+10.8pp) and away from Other (-10.5pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions. The portfolio's overlap with the prior quarter was 53% of names.

The largest new positions opened in Q3 2024 were BIOA ($47.94M), INCY ($47.21M), NVS ($23.00M).

Of the 26 positions fully exited versus the prior quarter, the largest were QQQ ($191.64M), ASND ($100.14M), SYK ($65.70M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • BIOA BIOAGE LABS INC · $47.94M
  • INCY INCYTE CORP · $47.21M
  • NVS NOVARTIS AG · $23.00M
  • JAZZ JAZZ PHARMACEUTICALS PLC · $21.01M
  • RYTM RHYTHM PHARMACEUTICALS INC · $14.50M
  • GH GUARDANT HEALTH INC · $9.33M
  • JANX JANUX THERAPEUTICS INC · $7.49M
  • ILMN ILLUMINA INC · $5.30M

Fully Exited (vs previous quarter)

  • QQQ INVESCO QQQ TR · prev qtr: $191.64M
  • ASND ASCENDIS PHARMA A/S · prev qtr: $100.14M
  • SYK STRYKER CORPORATION · prev qtr: $65.70M
  • ALGN ALIGN TECHNOLOGY INC · prev qtr: $52.76M
  • ABT ABBOTT LABORATORIES · prev qtr: $40.55M · history
  • IDXX IDEXX LABS INC · prev qtr: $31.11M
  • SRPT SAREPTA THERAPEUTICS INC · prev qtr: $30.94M
  • XBI SPDR SERIES TRUST · prev qtr: $23.18M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.0%
Other 7.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.55M $196.81M 16.45%
16.45%
Hold
2 2.79M $123.49M 10.32%
10.32%
Hold
3 726.33K $86.48M 7.23%
7.23%
Add
4 809.41K $63.06M 5.27%
5.27%
Add
5 1.75M $55.42M 4.63%
4.63%
Add
6 3.52M $51.69M 4.32%
4.32%
Add
7 2.30M $47.94M 4.01%
4.01%
New
8 714.18K $47.21M 3.95%
3.95%
New
9 2.00M $40.87M 3.42%
3.42%
Add
10 1.70M $39.87M 3.33%
3.33%
Hold
11 2.19M $28.85M 2.41%
2.41%
Hold
12 772.07K $27.73M 2.32%
2.32%
Reduce
13 2.27M $24.46M 2.04%
2.04%
Reduce
14 5.66M $24.01M 2.01%
2.01%
Add
15 200.00K $23.00M 1.92%
1.92%
New
16 4.28M $22.39M 1.87%
1.87%
Hold
17 188.56K $21.01M 1.76%
1.76%
New
18 286.31K $20.90M 1.75%
1.75%
Add
19 787.00K $15.15M 1.27%
1.27%
Reduce
20 300.00K $15.15M 1.27%
1.27%
Reduce
21 276.68K $14.50M 1.21%
1.21%
New
22 150.00K $13.48M 1.13%
1.13%
Reduce
23 202.90K $13.39M 1.12%
1.12%
Reduce
24 135.82K $11.38M 0.95%
0.95%
Reduce
25 600.30K $11.12M 0.93%
0.93%
Hold
26 384.77K $10.27M 0.86%
0.86%
Reduce
27 676.77K $9.89M 0.83%
0.83%
Add
28 406.64K $9.33M 0.78%
0.78%
New
29 203.27K $9.22M 0.77%
0.77%
Reduce
30 536.07K $8.39M 0.70%
0.70%
Add
31 358.64K $8.39M 0.70%
0.70%
Reduce
32 3.76M $7.86M 0.66%
0.66%
Hold
33 181.48K $7.85M 0.66%
0.66%
Reduce
34 4.39M $7.72M 0.65%
0.65%
Add
35 164.77K $7.49M 0.63%
0.63%
New
36 1.53M $7.24M 0.60%
0.60%
Add
37 1.51M $7.18M 0.60%
0.60%
Add
38 296.88K $5.80M 0.48%
0.48%
Reduce
39 238.18K $5.36M 0.45%
0.45%
Hold
40 40.61K $5.30M 0.44%
0.44%
New
41 1.84M $5.03M 0.42%
0.42%
Add
42 386.10K $4.41M 0.37%
0.37%
Reduce
43 90.33K $3.73M 0.31%
0.31%
Reduce
44 15.19K $3.66M 0.31%
0.31%
New
45 2.67M $3.66M 0.31%
0.31%
Hold
46 5.77K $3.57M 0.30%
0.30%
New
47 37.64K $2.56M 0.21%
0.21%
Reduce
48 41.35K $2.03M 0.17%
0.17%
Add
49 2.75M $1.78M 0.15%
0.15%
Hold
50 38.79K $1.70M 0.14%
0.14%
Add

FAQ

What did Sofinnova Investments, Inc. buy in 2024-Q3?

In its 2024-Q3 13F filing, Sofinnova Investments, Inc. reported 58 equity positions worth $1.20B in aggregate; its largest disclosed positions were NTRA ($196.81M), VERA ($123.49M), NVO ($86.48M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $1.20B of long equity holdings across 58 positions as of 2024-Q3. Top-10 holdings account for 62.9% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →